Delivery Order SPE2DX22D0020-SPE2D826F12SD
- Not listed
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order valued at $36,654.24 by the Defense Logistics Agency's Medical Supply Chain. This competitively awarded, firm fixed-price contract with an ultimate completion date of July 15, 2025, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The prime indefinite delivery vehicle,...
- Amerisourcebergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order valued at $166,128.90 by the Defense Logistics Agency's Medical Supply Chain on January 7, 2026. This firm fixed-price delivery order, which carries an ultimate completion date of January 8, 2026, represents a child contract under the parent entity Cencora, Inc. (doing business as Amerisourcebergen). The award was made through competitive procurement with...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order valued at $7,126.93 by the Defense Logistics Agency's Medical Supply Chain on June 16, 2025, with an ultimate completion date of June 17, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a child contract under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $167,368.32 on January 5, 2026, by the Defense Logistics Agency's Medical Supply Chain. The contract is firm fixed price with no set-aside designation and an ultimate completion date of January 6, 2026. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order valued at $67,624.38 by the Defense Logistics Agency's Medical Supply Chain on October 13, 2025. This competitively awarded, firm fixed-price contract with an ultimate completion date of October 14, 2025 represents a child delivery order under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The award carries no...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order valued at $816,525.26 by the Defense Logistics Agency's Medical Supply Chain. This competitive, non-set-aside contract is designated as a firm fixed price delivery order with an ultimate completion date of December 15, 2025. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $23,124.72 by the Defense Logistics Agency's Medical Supply Chain on December 13, 2025, with an ultimate completion date of December 15, 2025. This firm fixed-price contract, designated as a non-set-aside competitive award, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a comprehensive global...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order valued at $6,331.44 by the Defense Logistics Agency's Medical Supply Chain on November 17, 2025, with an ultimate completion date of November 18, 2025. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX...
- Amerisourcebergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $10,662.45 by the Defense Logistics Agency's Medical Supply Chain on January 6, 2026, with an ultimate completion date of January 7, 2026. This competitively awarded, firm fixed-price contract represents a child delivery order under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at up to...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $36,907.28 by the Defense Logistics Agency's Medical Supply Chain on August 6, 2025. This firm fixed-price contract, designated as a non-set-aside competitive award, represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The company serves as a critical vendor for...
- SPE2DX22D0020Indefinite Delivery Contract
- SPE2DX22D0020-SPE2D826F12SDDelivery Order
Amerisourcebergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $672,117.79 by the Defense Logistics Agency's Medical Supply Chain on January 7, 2026, with completion expected by January 8, 2026. This competitive award, issued under a firm fixed-price contract structure with no set-aside designation, represents a child delivery order under Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The parent company, Cencora, Inc. (doing business as Amerisourcebergen), holds a significant $999.99 million IDC through December 2026, which serves as a comprehensive global pharmaceutical support vehicle enabling the delivery of a broad range of pharmaceutical products, medical supplies, specialty medications, vaccines, and other critical healthcare commodities to support military healthcare programs worldwide. This delivery order exemplifies Amerisourcebergen's established role as a critical federal pharmaceutical vendor serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's federal contract portfolio demonstrates consistent capability in supplying diverse pharmaceutical products across multiple therapeutic domains, including diabetes medications, neurological treatments, pain management pharmaceuticals, and specialized medical supplies. The firm fixed-price delivery order structure and competitive award methodology reflect Amerisourcebergen's proven ability to meet federal procurement requirements while supporting military medical operations and veteran healthcare programs on a global scale.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $672.1k | 1/6/26 |